Ignite Creation Date:
2024-05-06 @ 1:41 AM
Last Modification Date:
2024-10-26 @ 11:08 AM
Study NCT ID:
NCT01870505
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2013-06-03
Brief Title:
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-03
First Submit QC Date:
June 3 2013
Study First Post Date:
2013-06-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-01
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL